Back
Novanta Vs. Lemonade Industry Stock Comparison
Buy
54
NOVT
Novanta
Last Price:
164.72
Seasonality Move:
10.13%
Buy
99
LMND
Lemonade
Last Price:
50.35
Seasonality Move:
18.32%
Buy
54
Novanta (NOVT)
is a Buy
Is Novanta a Buy, Sell or Hold?
- The current Novanta [NOVT] share price is $164.94. The Score for NOVT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- NOVT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
99
Lemonade (LMND)
is a Buy
Is Lemonade a Buy, Sell or Hold?
- The current Lemonade [LMND] share price is $46.58. The Score for LMND is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- LMND is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
LMND Stock Price Chart
NOVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.07 | Sell |
Relative Strength Index (14 RSI): | 39.12 | Sell |
Chaikin Money Flow: | 105562 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
LMND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.44 | Buy |
Relative Strength Index (14 RSI): | 86.66 | Buy |
Chaikin Money Flow: | 4128079 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
NOVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 169.74 | Sell |
20-day SMA: | 173.01 | Sell |
50-day SMA: | 173.67 | Sell |
200-day SMA: | 169.13 | Sell |
8-day EMA: | 168.91 | Sell |
20-day EMA: | 171.86 | Sell |
50-day EMA: | 173.23 | Sell |
200-day EMA: | 168.86 | Sell |
LMND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.57 | Buy |
20-day SMA: | 27.95 | Buy |
50-day SMA: | 21.68 | Buy |
200-day SMA: | 18.44 | Buy |
8-day EMA: | 36.28 | Buy |
20-day EMA: | 30.07 | Buy |
50-day EMA: | 24.26 | Buy |
200-day EMA: | 19.36 | Buy |
Novanta Earnings Growth & NOVT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.76 per share.
Lemonade Earnings Growth & LMND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.28 per share.
Novanta Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lemonade Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |